Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 545301 - 545320 out of 553697 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 30MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 45MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 45MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01EB09) lazertinib | LAZCLUZE 240MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EB09) lazertinib | LAZCLUZE 240MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EB09) lazertinib | LAZCLUZE 80MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EB09) lazertinib | LAZCLUZE 80MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EC) b-raf serine-threonine kinase (braf) inhibitors | OJEMDA 25MG/ML SUSP,ORAL | 12ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DayOneBiopharmaceuticals,Inc. |
| USA | (L01EC) b-raf serine-threonine kinase (braf) inhibitors | OJEMDA 100MG TAB,PKT,4 | 16 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DayOneBiopharmaceuticals,Inc. |
| USA | (L01EC) b-raf serine-threonine kinase (braf) inhibitors | OJEMDA 100MG TAB,PKT,5 | 20 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DayOneBiopharmaceuticals,Inc. |
| USA | (L01EC) b-raf serine-threonine kinase (braf) inhibitors | OJEMDA 100MG TAB,PKT,6 | 24 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DayOneBiopharmaceuticals,Inc. |
| USA | (L01EC01) vemurafenib (adm: O) | ZELBORAF 240MG TAB | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | GenentechUSA,Inc. |
| USA | (L01EC01) vemurafenib (adm: O) | ZELBORAF 240MG TAB | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | GenentechUSA,Inc. |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 50MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 50MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 75MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 75MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 10MG TAB,SUSP,ORAL | 210 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 10MG TAB,SUSP,ORAL | 210 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC03) encorafenib (adm: O) | BRAFTOVI 75MG CAP,ORAL | 2X90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | PfizerInc. |
Pages
